Why Nektar Therapeutics Stock Plunged Today
Shares of Nektar Therapeutics (NASDAQ: NKTR) were plunging 19% as of 3:53 p.m. EDT on Friday. The big drop came after the company announced its third-quarter results following the market close on Thursday.
Nektar posted a net loss in the third quarter of $129.7 million, or $0.70 per share. This result was better than the average analysts' estimate of a Q3 loss of $0.80. However, the company's revenue of $24.9 million fell short of the consensus estimate of $27.9 million. The revenue figure also declined 17% year over year.
Image source: Getty Images.
Source Fool.com
